Bhagiradha Chemicals & Industries has informed that in relation to the Issue, the Board, at its meeting held on April 5, 2022, has approved the following: Issue Size and Price: Issue of up to 20,95,924 equity shares of face value Rs 10 each (Issue Shares) of our Company for cash at a price of Rs 400 per Equity Share (including a share premium of Rs 390 per Equity Share) (Issue Price), aggregating up to Rs 8,383.70 lakh by the Company. The issue comprises: an issue of up to 19,55,224 Equity Share to the Eligible Equity Shareholders of the Company on rights basis (Rights Equity Shares) aggregating up to 7,820.90 lakh in the ratio of 4 (four) Rights Equity Shares for every 17(seventeen) fully paid-up Equity Share held by the Eligible Equity Shareholders on the record date, that is on April 9, 2022; and a reservation of up to 1,40,700 Equity Share for the Eligible Employees of the Company (Employee Reservation Shares) aggregating up to Rs 562 80 lakh (Employee Reservation Portion); Rights Entitlement Ratio: 4 (four) Rights Equity Shares for every 17 (seventeen) fully paid-up Equity Shares held by the Eligible Equity Shareholders of the Company; Fixed record date for the purpose of determining the shareholders who will be eligible to apply for the Issue as Saturday, April 09, 2022 (Record Date);
The above information is a part of company’s filings submitted to BSE.